Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCB-BO1301 + Dacarbazine in Advanced Melanoma
NCT02994498Phase 2Not yet recruiting
- Sponsor
- Chung Mei Biopharma
- Start
- Mar 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of DCB-BO1301 in melanoma, sponsored by Chung Mei Biopharma. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
DCB-BO1301
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02994498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02994498.